Diversity, Equity, and Inclusion in Oncology
-
Register
- Non-member - $40
- Member - Free!
The Diversity, Equity, and Inclusion in Oncology modules by APSHO include 8 comprehensive and self-paced modules to equip you with the understanding of health disparities, inequities and structural racism in the hematology/oncology setting and how these affect patient outcomes. (Additionally, one of the modules addresses health disparities and inequities in substance use disorders and this module meets the DEA requirement for training on substance use disorder.) 3.5 CE-Accredited Hours
-
Contains 5 Component(s), Includes Credits
0.75 CE-Accredited Hours
- Define substance use disorder (SUD) and describe health disparities related to this
- List factors contributing to health disparities in SUD
- Discuss the role of the advanced practitioner in addressing health disparities in the patient with SUD
Wendy Vogel
MSN, FNP, AOCNP, FAPO
APSHO, Executive Director
Wendy H. Vogel, MSN, FNP, AOCNP®, FAPO, is an oncology nurse practitioner from Kingsport, Tennessee. She received her Bachelor of Science in Nursing at Tennessee Technological University and her Master of Science in Nursing in the Family Nurse Practitioner Program at East Tennessee State University. Ms. Vogel is a board- certified advanced oncology certified nurse practitioner through the Oncology Nursing Certification Corporation and a certified family nurse practitioner through the American Nurses Credentialing Center.
As well as being the Executive Director and a founding Board member of APSHO (the Advanced Practitioner Society for Hematology and Oncology) , Ms. Vogel is an Associate Editor of JADPRO and has published in several professional journals. She received the 2012 ONS Mary Nowotny Excellence in Cancer Nursing Education Award as well as the American Journal of Nursing Book of the Year Award for co-editing the Advanced Oncology Nursing Certification Review and Resource Manual: Instructor’s Resource. She has lectured nationally and internationally on oncologic topics and the role of the advanced practitioner.
Wendy Vogel has no relevant financial relationships to disclose
Cyndi Davis
NP
Cayuga Cancer Center
Cyndi Davis has no relevant financial relationships to disclose
-
Contains 5 Component(s), Includes Credits
0.25 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)
- Define racism and summarize its impact on patient care.
- List different types of historical structural racism.
- State the role of the AP in dismantling structural racism.
F. Diane Barber
PhD, ANP-BC, AOCNP, FAANP, FAAN
Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program) University of Texas MD Anderson Cancer Center
F. Diane Barber has no relevant financial disclosures
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)
- Define health disparity and health inequity and describe contributing factors to these issues
- Define and illustrate social determinants of health
- List examples of health disparities in oncology/hematology
Cissimol Joseph
MSN, AGPCNP, AOCNP
M D Anderson Cancer Center
Cissimol Joseph has no relevant financial disclosures
Shamsah Lakhani
DHSc, MPH, PA-C
Medical Science Liaison Sanofi
Shamsah Lakhani is employed by Sanofi.
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)
- Differentiate between health disparity versus health inequity
- Discuss how race, ethnicity, and socioeconomic status contribute to breast cancer disparities
- Describe the impact of culture, implicit bias, and institutional racism on treatment outcomes and mortality
Rose Dimarco
PharmD, BCPS, BCOP
Jefferson Health’s Sidney Kimmel Cancer Center
Dr. Rose DiMarco is an advanced clinical pharmacist of oncology at Jefferson Health’s Sidney Kimmel Cancer Center, specializing in breast and gynecologic cancer care. She presents at Jefferson’s Cancer Support Center to members of the community on topics such as Chemotherapy Side Effects, Targeted Therapy, Supportive Care Management, and Insomnia in Cancer, and is an Advanced Pharmacy Practice Experience preceptor for pharmacy students looking to gain education and training in oncology. Dr. DiMarco is a member of the Hematology/Oncology Pharmacy Association and serves on APSHO’s Diversity, Equity, and Inclusion Committee.
Dr. DiMarco has the following relevant financial relationship to disclose:
- Bristol Myers Squibb Advisory Board for Oncology – Immunotherapy
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)
- Articulate the impact of colorectal cancer (CRC) in Black individuals in terms of mortality
- Identify the disparities in CRC in screening, diagnosis, and treatment
- Describe the advanced practitioner role in screening and the impact on racial and ethnic survival disparities
Lisania Milli
MSN, RN, WHNP-BC
Memorial Sloan Kettering Cancer Center
Lisania Milli has no relevant financial relationships to disclose
Kristen O’Hagan
MSN, RN, ANP-BC, AOCNP
Memorial Sloan Kettering Cancer Center
Kristen O’Hagan has no relevant financial relationships to disclose
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours
- Articulate the impact of lung cancer health disparity in various populations
- Identify the disparities in lung cancer in screening, diagnosis, and treatment
- Describe the advanced practitioner role in lung cancer screening and the impact on racial and ethnic survival disparities
Kristen O’Hagan
MSN, RN, ANP-BC, AOCNP
Memorial Sloan Kettering Cancer Center
Kristen O’Hagan has no relevant financial relationships to disclose
Lisania Milli
MSN, RN, WHNP-BC
Memorial Sloan Kettering Cancer Center
Lisania Milli has no relevant financial relationships to disclose
-
Contains 5 Component(s)
Non-CE-accredited module
- Describe disparities in prostate cancer prevalence and outcomes
- Identify the social determinants related to prostate cancer outcomes
- Assess barriers to screening and treatment in local communities
Shamsah Lakhani
DHSc, MPH, PA-C
Medical Science Liaison Sanofi
Shamsah Lakhani is employed by Sanofi.
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours
- Describe the importance of including diverse populations in clinical trials
- Identify strategies to improve diversity, inclusion, and equity in clinical trials
- List barriers or perceptions that prevent or limit diversity, inclusion, and equity in clinical trials
F. Diane Barber
PhD, ANP-BC, AOCNP, FAANP, FAAN
Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program) University of Texas MD Anderson Cancer Center
F. Diane Barber has no relevant financial disclosures
